Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations

BACKGROUND: Women with inherited mutations in the BRCA1 or BRCA2 genes have increased lifetime risks for developing breast and/or ovarian cancer and may develop these cancers around the age of 30 years. Therefore, prevention of breast and ovarian cancer in these women may need to start relatively ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallsson, Lára R., Sroczynski, Gaby, Engel, Jutta, Siebert, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294312/
https://www.ncbi.nlm.nih.gov/pubmed/37365514
http://dx.doi.org/10.1186/s12885-023-10956-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294312/
https://www.ncbi.nlm.nih.gov/pubmed/37365514
http://dx.doi.org/10.1186/s12885-023-10956-6

Ejemplares similares